Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosyltransferases are a large family of enzymes (EC 2.4) that catalyze the transfer of sugar moieties from activated donor molecules to specific acceptor molecules, forming glycosidic bonds. They are essential for the biosynthesis and modification of glycans, playing a central role in protein glycosylation, glycolipid formation, cell signaling, immune recognition, and molecular stability. Defects in these enzymes can cause congenital disorders of glycosylation and other metabolic diseases. Some bacterial pathogens utilize glycosyltransferases to modify adhesin proteins for host colonization.
Catalyzes the transfer of sugar moieties from activated donor molecules (typically nucleotide sugars) to specific acceptor molecules, forming glycosidic bonds.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosyltransferase (GT).